12 Health Care Stocks Moving In Monday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Monday's pre-market session, several healthcare stocks showed significant movement. Monogram Orthopaedics, Allarity Therapeutics, VYNE Therapeutics, Allogene Therapeutics, Sunshine Biopharma, and Addex Therapeutics were among the gainers, with increases ranging from 12.4% to 19.1%. Conversely, GlycoMimetics, Acutus Medical, EyePoint Pharmaceuticals, NeuBase Therapeutics, Ocular Therapeutix, and Predictive Oncology experienced declines between 13.82% and 78.7%.
May 06, 2024 | 12:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Allarity Therapeutics shares moved upwards by 13.99% to $1.14, with a market value of $2.2 million.
The pre-market gain for ALLR indicates a positive market response, potentially due to favorable company developments, suggesting a likely short-term positive impact on its stock price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Monogram Orthopaedics stock increased by 19.1% to $2.31, with a market cap of $73.1 million.
The significant pre-market increase in MGRM's stock price suggests positive investor sentiment or reaction to recent company news, likely leading to a short-term upward price movement.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Acutus Medical shares fell 38.57% to $0.09, with a market value of $2.6 million.
AFIB's significant pre-market drop suggests a negative market reaction, possibly due to unfavorable company news or financial results, indicating a likely short-term negative impact on its stock price.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 90
NEGATIVE IMPACT
GlycoMimetics shares decreased by 78.7% to $0.39, with a market value of $25.0 million.
The drastic pre-market decline in GLYC's stock price likely reflects negative investor sentiment or adverse news related to the company, predicting a significant short-term negative impact on its stock price.
CONFIDENCE 90
IMPORTANCE 100
RELEVANCE 90